This inventor holds 1 USPTO granted patent. Top assignee: Ludwig Institute for Cancer Research Limited. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: Lothar Hultner: Innovator in Mast Cell Research
Introduction
Lothar Hultner is a distinguished inventor based in Munich, Germany. He has made significant contributions to the field of immunology, particularly in the study of mast cells. His innovative work has led to the development of a unique method that enhances the growth and proliferation of these important immune cells.
Latest Patents
Hultner holds a patent for a method that utilizes the glycoprotein known as P40. This glycoprotein, characterized by a molecular weight of approximately 30 to 40 kilodaltons and an isoelectric point of about 10, has been recognized as a helper T cell growth factor. His research demonstrates that P40 also enhances the growth and proliferation of mast cells, while maintaining their viability and differentiation status in vitro. This patent represents a significant advancement in understanding mast cell biology and its implications for immune response.
Career Highlights
Lothar Hultner is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to explore the complexities of immune cell behavior. His work has been instrumental in advancing the scientific community's understanding of mast cells and their role in various diseases.
Collaborations
Hultner has collaborated with notable colleagues, including Jochen Moeller and Catherine Uyttenhove. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in the field.
Conclusion
Lothar Hultner's contributions to mast cell research through his innovative patent and collaborative efforts highlight his role as a key figure in immunology. His work continues to pave the way for future advancements in understanding immune responses and potential therapeutic applications.